Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Dexmedetomidine for Delirium after Cardiac Surgery
NCT06756178Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of remimazolam in postoperative delirium (POD) (3 arms), sponsored by Assiut University. Primary endpoint: Postoperative Delirium (POD) at 5 days. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06756178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756178.